Please find enclosed unaudited financial result for half year ended Sep 26

TEJNAKSH HEALTHCARE LIMITED Regd. Office : Shop No. 1, Shivprasad Harihar Singh Compound, Jogeshwari East, Caves Road, Pratap Nagar, Mumbai, Maharashtra - 400060 Head Office : Institute of Urology Sakri Raod, Dhule - 424001 CIN : L85100MH2008PLC179034, E-mail : Instituteofurology@gmail.com Website : www.tejnaksh.com | Tel. No. 022-27454 2311, 02562 - 245322 / 245995 Date: 12-11-2026 BSE Limited PhirozeJeejeebhoy Towers. Dalal Street, Mumbai — 400 001 Dear Sir/Madam, Scrip Code: 539428 Subject: Submission of Un-Audited Financial Results (Standalone & Consolidated) for the Quarter ended on 30" September, 2026. Please find the enclosed herewith Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended on 30" September, 2026 along with Limited Review Report thereon approved by the Board of Directors of the Company at its Meeting held on Thursday, 12 November, 2026 at Shop No 1 Building Name: Shivprasad Harihar Singh Compound, Block Sector: Jogeshwari East, Road: Caves Road. Pratap Nagar -Mumbai, Maharashtra, 400060 at 3:00 p.m., in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and record. Thanking you. For Tejnaksh Healthcare Limited Dr. Ashish V. Rawandale Managing Director DIN: - 02005733 Maheshwari & Co. Chartered Accountants Independent Auditor’s Review Report on Unaudited Standalone Financial Results of Tejnaksh Healthcare Limited for the Quarter and half year ended September 30, 2026 pursuant to the Regulation 33 of The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Review Report to, The Board ofD irectors Tejnaksh Healthcare Limited 1. We have reviewed the accompanying statement of unaudited standalone financial results of Tejnaksh Healthcare Limited (‘hereinafter referred to as ‘the Company’) for the quarter and half year ended September 30, 2026 (the ‘Statement’), attached herewith, being submitted by the Company pursuant to the requirements of the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Regulations”). 2. This Statement which is the responsibility of the Company's Management and has been approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" (*Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 (‘the Act) as amended, read with relevant rules issued thereunder (‘Ind AS 34') and other recognized accounting principles generally accepted in India and is in compliance with the regulations. Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Attention is drawn to the fact that the figures for the quarter ended September 30, 2026, as reported in the Statement, represent the balancing figures between the unaudited figures for the half year ended September 30, 2026, and the published unaudited figures for the quarter ended June 30, 2026. The figures up to the end of the second quarter of financial year had only been reviewed and not subjected to audit 5. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognized accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Regulations, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Maheshwari & Co. Chartered Accountants Firm’s Registr: Membership No.: 172133 UDIN: 26172133MJRAPR5229 Place: Mumbai Date: November 12, 2026 Office: 1302/1303, Solaris One, Vijay Nagar, Opp. Teli Gali, Andheri (East), 400069 Head office: 10-11, Third Floor, Esplanade Building, 3 A K Naik Marg, Near New Empire Cinema, Fort, CST, Mumbai 400 001 Tel.: +91-22-22077472/22072620, E-mail: vkasawa@maheshwariandco.in, Website: www.maheshwariandco.in TEJNAKSH HEALTHCARE LIMITED Regd. Office : Shop No. 1, Shivprasad Harihar Singh Compound, Jogeshwari East, Caves Road, Pratap Nagar, Mumbai, Maharashtra - 400060 Head Office : Institute of Urology Sakri Raod, Dhule - 424001 CIN : L85100MH2008PLC179034, E-mail : Instituteofurology@gmail.com Website : www.tejnaksh.com | Tel. No. 022-27454 2311, 02562 - 245322 / 245995 TEJNAKSH HEALTHCARE LIMITED (CIN: L85100MH2008PLC179034) Standalone Balance Sheet As At September 30, 2026 All amounts are in Indian Rupees lakhs Non-current assets Property, plant and equipment 1,703.48 1,738.14 Goodwill 147.61 168.70 Other intangible assets 093 0.95 Intangible assets under development 187.25 169.25 ROU assets 18.20 2427 Financial assets ~Investment 106.01 106.01 -Other financial assets 37837 226.54 Income tax assets (net) 3556 43.04 Other non current assets 0.63 0.74 Total non-current assets 2,578.04 2,477.64 Current assets Inventories 4033 39.02 Financial assets -Trade receivables 21862 20173 -Cash and cash equivalents 136.46 17855 -Other bank balances 17.80 7.74 -Other financial assets 3.72 353 Other current assets 857 13.47 Total current assets 425.50 444.04 Total assets 3,003.54 2,921.68 EQUITY AND LIABILITIES Equity Equity share capital 1,015.68 1,015.68 Other equity 1,729.48 1,663.87 Total equity 2,745.16 2,679.55 Liabilities Non-current liabilities Financial liabilities -Borrowings - - -Lease Liability 7.03 13.66 -Other Financial Liability 3246 30.07 Provisions 8.60 8.78 Deferred Tax liabilities (Net) 150.20 g 146.40 Other non current liabilities 138 3.63 ‘Total non-current liabilities 199.67 202.54 Current liabilities Financial liabilities -Borrowings - - -Lease liability 1227 10.96 “Trade payables : Total outstanding dues of micro and small enterprises ; and : 027 - Total outstanding dues of creditors other than micro enterprises and small enterprises 3095 1107 Other Financial Liabilities 405 503 Other current liabilities 6.01 7.87 Provisions 5.16 4.66 Total current liabilities 58.71 39.59 Total liabilities 258.38 242.13 Total equity and liabilities 3,003.54 2,921.68 TEJNAKSH HEALTHCARE LIMITED Regd. Office : Shop No. 1, Shivprasad Harihar Singh Compound, Jogeshwari East, Caves Road, Pratap Nagar, Mumbai, Maharashtra - 400060 Head Office : Institute of Urology Sakri Raod, Dhule - 424001 CIN : L85100MH2008PLC179034, E-mail : Instituteofurology@gmail.com Website : www.tejnaksh.com | Tel. No. 022-27454 2311, 02562 - 245322 / 245995 TEJNAKSH HEALTHCARE LIMITED (CIN: L85100MH2008PLC179034) Standalone Cash Flow Statement for half year ended on Sepetember 30, 2026 All amounts are in Indian Rupees lakhs Cash flow from/(used in) operating acti Profit /(loss) before tax 92.30 Adjustment for: Depreciation and amortisation expense 65.16 131.32 Interest Income (9.75) (12.18) Finance costs 255 1317 Employee B [Showing first 8,000 characters — download PDF for full document]